Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing the Effectiveness of Low Dose Naltrexone for Smoking Cessation and Minimization of Post-cessation Weight Gain

NCT00105482 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00105482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00105482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing the Effectiveness of Low Dose Naltrexone for Smoking Cessation and Minimization of Post-cessation Weight Gain
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
October 31, 2009
Enrollment
172 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence